Moderna 1 article

The RNA platform of Moderna centers on mRNA therapeutics platform; as a mRNA biotechnology company, it also uses messenger RNA vaccine technology to shape delivery, specificity or RNA processing. Its RNA platform extends through lipid nanoparticle mRNA delivery and mRNA sequence engineering, while oncology mRNA immunotherapy distinguishes the delivery or transcript-level mechanism used to alter gene expression. For entity matching, the RNA modality is not interchangeable with the company; Moderna is also associated with rare disease mRNA therapeutics.